Kinetics of the reduction in viability of cultured L1210 leukemia cells exposed to 5-azacytidine (NSC-102816).

No abstract is available for this paper.

• Publication year

  1972

• Venue

  Cancer chemotherapy reports

• Publication date

  1972-10-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 4119906
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Kinetics of effect of 1-beta-D-arabinofuranosylcytosine, its 5'-palmitoyl ester, 1-beta-D-arabinofuranosyluracil, and tritiated thymidine on the viability of cultured leukemia L1210 cells.

  1972cited by this paper
• Kinetic evaluation of the effect of hydroxyurea on viability of replicating cultured leukemia L1210 cells.

  1970cited by this paper
• Phase specificity of 5-azacytidine against mammalian cells in tissue culture.

  1970cited by this paper
• Cytotoxicity and mode of action of 5-azacytidine on L1210 leukemia.

  1970cited by this paper
• 5-Azacytidine: Microbiological Assay in Mouse Blood

  1969cited by this paper
• Effects of 5-azacytidine on polyribosomes and on the control of tyrosine transaminase activity in rat liver.

  1969cited by this paper
• Inhibition of ribonucleoside diphosphate reductase by hydroxyurea.

  1968cited by this paper
• Inhibition of mammalian DNA polymerase by the 5'-triphosphate of 1-beta-d-arabinofuranosylcytosine and the 5'-triphosphate of 9-beta-d-arabinofuranoxyladenine.

  1968cited by this paper
• Effect of antimetabolites on kinetic behavior of proliferating cultured L1210 leukemia cells.

  1967cited by this paper
• Experimental evaluation of potential anticancer agents XV. On the relative rates of growth and host kill of "single" leukemia cells that survive in vivo cytoxan therapy.

  1966cited by this paper
• THE ACTIVITY OF A NEW ANTIMETABOLITE, 5-AZACYTIDINE, AGAINST LYMPHOID LEUKAEMIA IN AK MICE.

  1964cited by this paper
• 5-Azacytidine, a new, highly effective cancerostatic

  1964cited by this paper

• Azacitidine and the beginnings of therapeutic epigenetic modulation

  2008cites this paper
• 5-Azacytidine and Decitabine Monotherapies of Myelodysplastic Disorders

  2005cites this paper
• Multidrug resistance in solid tumours

  2004cites this paper
• MODULATION OF OSTEOGENIC DIFFERENTIATION IN HUMAN SKELETAL CELLS IN VITRO BY 5‐AZACYTIDINE

  1998cites this paper
• Induction of apoptosis by 5-azacytidine: drug concentration-dependent differences in cell cycle specificity.

  1995cites this paper
• The effects of 5-azacytidine and 5-azadeoxycytidine on chromosome structure and function: implications for methylation-associated cellular processes.

  1995cites this paper
• Metabolism of pyrimidine analogues and their nucleosides.

  1990cites this paper
• Biochemistry of azacitidine: a review.

  1987cites this paper
• Stability of azacitidine in infusion fluids.

  1984cites this paper
• Continuous infusion of 5-azacytidine as induction for acute nonlymphocytic leukemia in patients with previous exposure to 5-azacytidine.

  1983cites this paper
• Sequence-dependent toxicity and small bowel mucosal injury in neonatal mice treated with low doses of 5-azacytidine and X-irradiation at the late organogenesis stage

  1983cites this paper
• Differential killing efficacy of twenty antitumor drugs on proliferating and nonproliferating human tumor cells.

  1981cites this paper
• In vitro assays in preclinical antineoplastic drug screening.

  1981cites this paper
• 5-Azacytidine hydrolysis kinetics measured by high-pressure liquid chromatography and 13C-NMR spectroscopy.

  1979cites this paper
• Nonproliferating neoplastic cells in culture: behavior of the adenine nucleotides.

  1979cites this paper
• 5-Azacytidine: Mechanism of action and biological effects in mammalian cells

  1978cites this paper
• Isolation, characterization, and properties of a labile hydrolysis product of the antitumor nucleoside, 5-azacytidine.

  1978cites this paper
• In vitro cytotoxic and biochemical effects of 5-aza-2'-deoxycytidine.

  1977cites this paper
• Kinetic studies with 5-azacytidine-5'-triphosphate and DNA-dependent RNA polymerase.

  1977cites this paper
• Stem Cells, Nonproliferating Cells, and Their Kinetics in Normal and Neoplastic Tissues

  1977cites this paper
• Synthesis and antitumor activity of dihydro-5-azacytidine, a hydrolytically stable analogue of 5-azacytidine.

  1977cites this paper
• 5-Azacytidine. A new anticancer drug with effectiveness in acute myelogenous leukemia.

  1976cites this paper
• Inhibition of uridine-cytidine kinase by 5-azacytidine 5'-triphosphate.

  1976cites this paper
• The disposition and pharmacokinetics in humans of 5-azacytidine administered intravenously as a bolus or by continuous infusion.

  1976cites this paper
• Proliferation-dependent cytotoxicity of anticancer agents: a review.

  1975cites this paper
• In vitro biochemical and cytotoxicity studies with 1-beta-D-arabinofuranosylcytosine and 5-azacytidine in combination.

  1975cites this paper
• Kinetics of both leukemic and normal cell population reduction following 5-azacytidine.

  1975cites this paper
• Kinetic studies on phosphorylation of 5-azacytidine with the purified uridine-cytidine kinase from calf thymus.

  1974cites this paper